|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500095436 |
|
最近更新日期: Date of Last Refreshed on: |
2025-01-07 14:57:42 |
|
注册时间: Date of Registration: |
2025-01-07 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
预测早孕期妊娠丢失的特定TTV病毒载量指标建立及遗传进化分析 |
|
Public title: |
Establishment of specific TTV viral load indicators for predicting pregnancy loss in early pregnancy and analysis of genetic evolution |
|
注册题目简写: |
|
|
English Acronym: |
Specific TTV viral load indicators for predicting pregnancy loss in early pregnancy |
|
研究课题的正式科学名称: |
预测早孕期妊娠丢失的特定TTV病毒载量指标建立及遗传进化分析 |
|
Scientific title: |
Establishment of specific TTV viral load indicators for predicting pregnancy loss in early pregnancy and analysis of genetic evolution |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
林彩云 |
研究负责人: |
林彩云 |
|
Applicant: |
Caiyun Lin |
Study leader: |
Caiyun Lin |
|
申请注册联系人电话: Applicant telephone: |
+86 18670703171 |
研究负责人电话: Study leader's telephone: |
+86 898 36689081 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
lincaiyun@hainmc.edu.cn |
研究负责人电子邮件: Study leader's E-mail: |
lincaiyun@hainmc.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
海南省海口市琼山区龙昆南路75号 |
研究负责人通讯地址: |
海南省海口市琼山区龙昆南路75号 |
|
Applicant address: |
No.75, Longkunnan Road, Haikou, Hainan |
Study leader's address: |
No.75, Longkunnan Road, Haikou, Hainan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
海南省妇女儿童医学中心 |
||
|
Applicant's institution: |
Hainan Women and Children's Medical Center |
||
|
研究负责人所在单位: |
海南省妇女儿童医学中心 |
||
|
Affiliation of the Leader: |
Hainan Women and Children's Medical Center |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
HNWCMC伦审2024年第[76]号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
海南省妇女儿童医学中心医学伦理委员会 |
||
|
Name of the ethic committee: |
The Medical Ethics Committee of Hainan Women andChildren's Medical Center |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-04-09 00:00:00 |
||
|
伦理委员会联系人: |
罗庆 |
||
|
Contact Name of the ethic committee: |
Luo Qing |
||
|
伦理委员会联系地址: |
海南省海口市琼山区龙昆南路75号 |
||
|
Contact Address of the ethic committee: |
No.75, Longkunnan Road, Haikou, Hainan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 898 36391632 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
540010821@qq.com |
|
研究实施负责(组长)单位: |
海南省妇女儿童医学中心 |
||||||||||||||||||||||
|
Primary sponsor: |
Hainan Women and Children's Medical Center |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
海南省海口市琼山区龙昆南路75号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No.75, Longkunnan Road, Haikou, Hainan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
海南省自然科学基金青年基金项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Hainan Provincial Natural Science Foundation Youth Fund Project |
||||||||||||||||||||||
|
Target disease: |
Spontaneous abortion |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
病例对照研究 |
||||||||||||||||||||||
|
Study design: |
Case-Control study |
||||||||||||||||||||||
|
研究目的: |
1.明确所建立的TTV检测方法作为标准化检测方法的可行性; 2.确定一个全新的预测早孕期妊娠丢失的临床检测指标并阐明其临床应用价值; 3.构建TTV感染在早孕期女性中的遗传进化树。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.To clarify the feasibility of the established TTV test as a standardised test; 2.To identify a novel clinical test for predicting pregnancy loss in early pregnancy and to elucidate its value for clinical application; 3.To construct a genetic evolutionary tree of TTV infection in women with early pregnancy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.早孕期符合稽留流产、人工流产诊断标准的妇女; |
||||||||||||||||||||||
|
Inclusion criteria |
1. Women who fulfil the diagnostic criteria for induced abortion and induced miscarriage in early pregnancy; 2. aged between 20-35 years old; 3. sufficient chorionic villus and blood samples could be collected and the source of the samples was clearly documented; 4. all volunteers have the right to information and must be approved by the Ethics Committee of the hospital; 5. clinical information should be complete: sampling unit, age, ethnicity, usual residence, marital and childbearing history, menstrual history, sample retention time, preoperative gynaecological ultrasound results, and the results of the aborted chorionic villus CNV test. |
||||||||||||||||||||||
|
排除标准: |
1.非孕期或者超过早孕期的妇女; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Women who are not pregnant or beyond early pregnancy; 2. women who are participating in any clinical trial; 3. incomplete clinical information or insufficient sample size; 4. with autoimmune diseases; 5. in the period of acute reproductive tract infection; 6. with serious diseases of heart, liver, kidney and other important organs; 7. having a history of organ or cell transplantation and a history of diseases requiring long-term. medication. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-04-10 00:00:00至 To 2027-02-28 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-05-06 00:00:00 至 To 2026-05-05 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
女性 |
Gender: |
Female |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
预计在2027年通过论文发表的方式共享原始数据。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Raw data sharing through paper publication expected in 2027. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
临床人员于入组日开始由电子病历系统采集临床数据,定期将临床数据及实验数据保存至EDC系统 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Clinical staff start to collect clinical data from the electronic medical record system on the day of enrolment, and save the clinical data and experimental data to the EDC system regularly. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |